top of page
Katarina Maiboe
MSc, PhD
Regulatory Affairs
A seasoned regulatory strategist, Katarina has 20+ years of international experience in drug development. Katarina has successfully led global regulatory strategies and interactions with FDA, EMA, PMDA, and other major agencies, with her most notable experience being semaglutide (Ozempic) which she worked on from Phase 1 through global approvals. She brings a breadth of experience from areas such as diabetes, obesity, CNS, and rare diseases.

bottom of page